Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Ondine Biomedical Inc. Rises 12.13% as Steriwave Adoption and Clinical Catalysts Strengthen Healthcare Optimism

Ondine Biomedical Inc. rose by 12.13% during the session, signalling stronger short-term investor sentiment. The movement appears to reflect renewed positioning around upcoming clinical developments and growing commercial evidence for Steriwave rather than a newly announced event during the session.

Ankur Sharma | 01 September 2026

Oxford Biomedica Shares Sink: Gene Therapy Bellwether Under Pressure

Shares in Oxford Biomedica (LSE:OXB) fell heavily in today's session, dropping 44.00p to close at 480.00p, a decline of 8.40%. That leaves the company with aMarket Capitalisationof approximately £634.27m. The move places Oxford Biomedica among the sharpest fallers on the London market today, a …

Divya Sood | 01 September 2026

Shield Therapeutics Shares Climb 10.91% as ACCRUFeR Growth and Profitability Progress Strengthen Investor Confidence

Shield Therapeutics shares rose by 10.91% as investors assessed encouraging interim results and a more credible route toward operating profitability. The company delivered strong groupRevenuegrowth, narrowed its overall loss and generated improved operating cash flow.

Ankur Sharma | 01 September 2026

Fusion Antibodies Stock Jumps as Scientific Progress and Commercial Recovery Fuel Investor Optimism

Fusion Antibodies shares rose by 19.05% during the session, reflecting strong upside pressure and renewed investor interest in the company’s recovery and technology-development strategy. The advance appears to have been driven by a reassessment of recent operational progress rather than one clearly identifiable announcement …

Ankur Sharma | 01 September 2026

Kooth PLC Stock Surges as Digital Mental Health Momentum Fuels Investor Optimism

Kooth PLC attracted strong buying interest during the session, with the shares advancing by 20.00%. The move suggests that investors reassessed the company’s near-termEarningstrajectory and longer-term US opportunity following encouraging operational commentary.

Ankur Sharma | 01 September 2026

Shield Therapeutics LSE:STX Rallies Sharply: US Commercial Rights, Profitability and Prescription Growth Drive Investor Attention

Shield Therapeutics plc became one of the most closely watched small-cap healthcare stocks on28 August 2026, withLSE:STX rising 10.91% to 6.10p.

Ankur Sharma | 31 August 2026

LSE:AREC Gains 8.03% as Ultra-Rapid U500 Insulin Programme Strengthens Arecor’s Growth Story

Arecor Therapeutics PLC has become one of the more closely watched UK healthcare small caps afterLSE:AREC jumped 8.03% to 74p on 28 August 2026.

Ankur Sharma | 31 August 2026

LSE:FAB Stock Surges 19.05%: Can Fusion Antibodies Turn Its Antibody Technology Into a Major Growth Platform?

Fusion Antibodies plc emerged as one of the strongest-performing small-cap healthcare stocks on28 August 2026, withLSE:FAB rising 19.05% to 12.50p.

Ankur Sharma | 31 August 2026

Kooth LSE:KOO Stock Rallies Sharply: California, Michigan and Soluna Growth Drive Investor Attention

Kooth plc was one of the most closely watched small-cap healthcare stocks on28 August 2026, withLSE:KOO rising 20.00% to 195p.

Ankur Sharma | 31 August 2026

Ondine Biomedical Stock News: Why LSE:OBI Investors Are Watching Phase 3 Results

Ondine Biomedical Inc. was one of the notable healthcare movers on 28 August 2026, with shares rising4.91% to 11.75p.

Ankur Sharma | 31 August 2026
Support

Hi! How can we help you today?

Loading…